The second Gran Turismo 7 Time Trial for 2026 is here and I can guarantee driving the Lexus LC500 around Watkins Glenn is ...

SELLAS Life Sciences Group (SLS) is back on traders’ radar after fresh data from its leukemia program, including strong response rates and supportive FDA designations, helped spark a sharp move in the ...

SELLAS Life Sciences Group Inc (NASDAQ: SLS) shares are trading higher on Monday after initially dropping in premarket trading, reversing course as investors seem to react to new trial‑related updates ...

SELLAS released positive results from its Phase 2 clinical trial for an investigational leukemia drug in early December. The company is also expected to release the final event-driven analysis for its ...

KENNEDY SPACE CENTER — Citing the proposed budget cuts by the Trump administration, NASA announced on Friday that after the Artemis III mission — where Americans will return to the moon — the rocket ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

About SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for ...

About SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for ...